Synthesis and Exploitation of the Biological Profile of Novel Guanidino Xylofuranose Derivatives
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F22%3A73616089" target="_blank" >RIV/61989592:15310/22:73616089 - isvavai.cz</a>
Result on the web
<a href="https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202200180" target="_blank" >https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202200180</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/cmdc.202200180" target="_blank" >10.1002/cmdc.202200180</a>
Alternative languages
Result language
angličtina
Original language name
Synthesis and Exploitation of the Biological Profile of Novel Guanidino Xylofuranose Derivatives
Original language description
The synthesis and biological evaluation of novel guanidino sugars as isonucleoside analogs is described. 5-Guanidino xylofuranoses containing 3-O-saturated/unsaturated hydrocarbon or aromatic-containing moieties were accessed from 5-azido xylofuranoses via reduction followed by guanidinylation with N,N '-bis(tert-butoxycarbonyl)-N ''-triflylguanidine. Molecules comprising novel types of isonucleosidic structures including 5-guanidino 3-O-methyl-branched N-benzyltriazole isonucleosides and a guanidinomethyltriazole 3 '-O-dodecyl xylofuranos-5 '-yl isonucleoside were accessed. The guanidinomethyltriazole derivative and a 3-O-dodecyl (N-Boc)guanidino xylofuranose were revealed as selective inhibitors of acetylcholinesterase (K-i=22.87 and 7.49 mu M, respectively). The latter also showed moderate antiproliferative effects in chronic myeloid leukemia (K562) and breast cancer (MCF-7) cells. An aminomethyltriazole 5'-isonucleoside was the most potent molecule with low micromolar GI(50) values in both cells (GI(50)=6.33 mu M, 8.45 mu M), similar to that of the drug 5-fluorouracil in MCF-7 cells. Moreover, the most bioactive compounds showed low toxicity in human fibroblasts, further indicating their interest as promising lead molecules.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30107 - Medicinal chemistry
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
ChemMedChem
ISSN
1860-7179
e-ISSN
1860-7187
Volume of the periodical
17
Issue of the periodical within the volume
14
Country of publishing house
DE - GERMANY
Number of pages
11
Pages from-to
"e202200180-1"-"e202200180-11"
UT code for WoS article
000804905400001
EID of the result in the Scopus database
2-s2.0-85131153304